Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries

CompletedOBSERVATIONAL

Enrollment

926

Participants

Timeline

Start Date

February 11, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Colorectal Cancer

Interventions

DIAGNOSTIC_TEST

Biosensor Point of Care Device

This device is a point of care urine-based metabolomic diagnostic test that detects metabolite biomarkers for CRC and polyps.

Trial Locations (5)

Endoscopy Unit, Obafemi Awolowo University Teaching Hospitals, Ile-Ife

Endoscopy Unit, University of Ilorin Teaching Hospital, Ilorin

Federal Medical Center, Owo

Endoscopy Unit, University College Hospital, Ibadan

Ladoke Akintola University Teaching Hospital, Osogbo

All Listed Sponsors

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

Obafemi Awolowo University Teaching Hospital

OTHER

NCT03173729 - Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries | Biotech Hunter | Biotech Hunter